Revenue
-1.93 million USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: -1929000 USD Source
Market value
$106.13M
18,346,473 shares as of 2026-11-09, at $5.785 a share (NAKA, IEX close on 2026-11-12) Primary-source evidence
Annual consolidated revenue for 2025: about USD 1.821M, using the latest reported figures. The previous period, 2024, was about USD 2.72M.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
Window: transactions dated on or after 2025-11-18.
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
-1.93 million USD
2026 Q3 · USD
-4,765.32%
2026 Q3 · %
-10.3 million USD
2026 Q3 · USD
-10.4 million USD
2026 Q3 · USD
19420000 USD
18346473 shares
-95.70% · -409 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-11-16.
Financial data available through: 2025-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 2.72 million
–
Current period
USD 1.82 million
–
1821315 − 2719840 = -898525 USD
2719840 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source1821315 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 3.62 million
–
Current period
−USD 52.23 million
–
-52228923 − -3617647 = -48611276 USD
-3617647 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-52228923 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 3.07 million
–
Current period
−USD 23.51 million
–
-23511499 − -3073891 = -20437608 USD
-3073891 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-23511499 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | 3768598 | 5388818 Derived | -1620220 | -2759 Derived | -1617461 | -463909 Derived | Source
|
| 2024 2024-01-01 – 2024-12-31 | 2719840 | 6066611 Derived | -3346771 | 270876 Derived | -3617647 | -3087184 Derived | Source
|
| 2025 2025-01-01 – 2025-12-31 | 1821315 | 198960557 Derived | -197139242 | -144910319 Derived | -52228923 | Unavailable | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Revenue | 3768598 |
|
| 2024 | Revenue | 2719840 |
|
| 2025 | Revenue | 1821315 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Year over year | No prior comparable period |
|
| 2024 | Year over year | -27.8% |
|
| 2025 | Year over year | -33% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Operating margin | -43% |
|
| 2024 | Operating margin | -123.1% |
|
| 2025 | Operating margin | -10,824% |
|
| 2023 | Net margin | -42.9% |
|
| 2024 | Net margin | -133% |
|
| 2025 | Net margin | -2,867.6% |
|
| 2023 | Free cash flow margin | -12.3% |
|
| 2024 | Free cash flow margin | -113.5% |
|
| 2025 | Free cash flow margin | Not reported |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Operating cash flow | -449489 |
|
| 2024 | Operating cash flow | -3073891 |
|
| 2025 | Operating cash flow | -23511499 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2023 | Free cash flow | -463909 |
|
| 2024 | Free cash flow | -3087184 |
|
| 2025 | Free cash flow | Unavailable |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Liabilities / assets | 109.9% |
|
| 2024 | Liabilities / assets | 30.2% |
|
| 2025 | Liabilities / assets | 29.6% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2023 | Current assets / current liabilities | 0.76× |
|
| 2024 | Current assets / current liabilities | 4.13× |
|
| 2025 | Current assets / current liabilities | 1.04× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2023 2023-01-01 – 2023-12-31 | −USD 1.62 million Exact valueExact value: -1617461 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 449,489 Exact valueExact value: -449489 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 14,420 Exact valueExact value: 14420 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 463,909 Calculation and evidence-449489 − 14420 USD Exact free cash flow: -463909 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 3.62 million Exact valueExact value: -3617647 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.07 million Exact valueExact value: -3073891 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 13,293 Exact valueExact value: 13293 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.09 million Calculation and evidence-3073891 − 13293 USD Exact free cash flow: -3087184 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2025-01-01 – 2025-12-31 | −USD 52.23 million Exact valueExact value: -52228923 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 23.51 million Exact valueExact value: -23511499 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
23 filings · 1,080 latest values · 1,119 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001946573, 1946573, NAKA, edgar:1946573
Also known as KINDLY MD, INC., KINDLY MD, INC., Kindly MD, Inc., NAKAMOTO INC., Nakamoto Inc.